Name: Break it Down: One step closer to treating ALS
Uploaded: 2025-03-24T15:42:58+11:00
Channel: Stockhead TV
Description: Neurizon Therapeutics (ASX:NUZ) continues to make strides on its NUZ-001 treatment for ALS, paving the way for next stage clinical trials.

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.

In this episode, Tylah Tully gives the skinny on Neurizon Therapeutics (ASX:NUZ) HEALEY ALS Platform Trial, as the company makes progress developing its lead asset NUZ-001.

Tune in to get the latest.